Dishman Carbogen Amcis Ltd.

View in App
165.05 +1.85 ▲1.1%

26 September 2023, 04:01:00 PM
Volume: 22,082

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.dishmangroup.com
Market Cap 2,593.19 Cr.
Enterprise Value(EV) 4,228.53 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -1.07 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-06
Industry PE 37.33 Trailing Twelve Months Ending 2023-06
Book Value / Share 371.64 Trailing Twelve Months Ending 2023-06
Price to Book Value 0.44 Calculated using Price: 165.05
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 15.68 Cr. 156,783,095 Shares
FaceValue 2
About Dishman Carbogen Amcis Ltd.
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Dishman Carbogen Amcis Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Dishman Carbogen Amcis Ltd. Performance

View details >>
1 Day
+1.13%
1 Week
+7.04%
1 Month
+7.98%
3 Month
+19.04%
6 Month
+29.05%
1 Year
+69.72%
2 Year
-17.84%
5 Year
-34.20%
10 Year

Dishman Carbogen Amcis Ltd. Fundamental Ratios

View details >>
7 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3,654.02 6.05 4.01 2.86 -2.89 0.32 -0.52
Return on Capital Employed (%) 4.60 4.67 5.79 3.93 -0.26 0.76 0.43
Return on Assets (%) 2.21 2.25 2.90 2.04 -2.00 0.21 -0.33

Dishman Carbogen Amcis Ltd. Balance Sheet

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 4,814 5,107 5,379 5,715 5,699 5,549 5,810
Non Curr. Liab. 767 884 743 909 1,367 1,665 1,831
Curr. Liab. 994 1,178 1,198 1,569 1,290 1,420 1,798
Minority Int.
Equity & Liab. 6,574 7,169 7,321 8,193 8,356 8,634 9,439
Non Curr. Assets 5,241 5,623 5,767 6,414 6,652 6,795 7,521
Curr. Assets 1,333 1,546 1,554 1,779 1,704 1,839 1,918
Misc. Exp. not W/O
Total Assets 6,574 7,169 7,321 8,193 8,356 8,634 9,439

Dishman Carbogen Amcis Ltd. Profit and Loss

View details >>
Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 1,714 1,695 2,059 2,044 1,912 2,141 2,413 2,596
Other Income 26 53 54 44 39 49 28 29
Total Income 1,740 1,748 2,112 2,088 1,951 2,190 2,441 2,624
Total Expenditure -1,260 -1,257 -1,507 -1,546 -1,638 -1,815 -2,081 -2,230
PBIDT 479 491 606 542 313 375 360 394
Interest -49 -49 -57 -62 -48 -57 -86 -95
Depreciation -214 -211 -240 -283 -308 -308 -281 -276
Taxation -71 -76 -98 -39 -100 22 25 8
Exceptional Items -22 -15 -48 -48
PAT 145 155 210 159 -165 18 -30 -17
Minority Interest
Share Associate
Other Related Items 15
Consolidated Net Profit 161 155 210 159 -165 18 -30 -17
Adjusted EPS 10 13 10 -11 1 -2 -1

Dishman Carbogen Amcis Ltd. Cash Flow

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 303 226 282 585 513 355 220
Cash Fr. Inv. -142 -297 -169 -442 -380 -619 -448
Cash Fr. Finan. -137 78 -102 -98 -11 130 250
Net Change 23 7 11 46 122 -133 22
Cash & Cash Eqvt 59 66 76 122 244 110 132

Dishman Carbogen Amcis Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 59.32 59.32 59.32 59.32 59.32 59.32 59.32 59.32 59.32
Public 40.68 40.68 40.68 40.68 40.68 40.68 40.68 40.68 40.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Dishman Carbogen Amcis Ltd. Announcements

View details >>
Fri, 22 Sep 2023
Closure of Trading Window
Pls. find attached herewith the intimation of closure of Trading Window.
Thu, 21 Sep 2023
DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015: SUCCESSFUL COMPLETION OF EDQM INSPECTION OF COMPANY'S BAVLA SITE
Pls. find attached herewith the disclosure pursuant to Regulations 30 and 51 of SEBI (LODR) Regulations 2015 pertaining to successful completion of EDQM Inspection of Companys Bavla Site.
Tue, 19 Sep 2023
Compliance-57 (4) : Prior intimation to the beginning of the quarter
Pls. find attached herewith intimation under regulation 57(4) of SEBI (LODR) Regulations 2015.

Dishman Carbogen Amcis Ltd. Technical Scans

View details >>
Tue, 26 Sep 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Dishman Carbogen Amcis Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,865.20 1,124.75 +0.1%
Divi's Laboratories Ltd. 99,629.03 3,752.95 +0.6%
Cipla Ltd. 93,955.61 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. 91,199.58 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. 72,659.42 5,051.00 -0.9%
Mankind Pharma Ltd. 70,114.99 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. 61,876.29 1,831.00 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.99 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-06 67.44 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-06 30.20 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.31 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.63 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 54.64 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.18 1,831.00 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-06 7.59 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-06 3.86 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.72 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.58 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 5.72 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.42 1,831.00 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,831.00 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,831.00 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,831.00 -0.9%

Dishman Carbogen Amcis Ltd. FAQ's

What is Dishman Carbogen Amc share price?
Can I buy Dishman Carbogen Amc shares now?
What is the Market Cap of Dishman Carbogen Amc?
What are the key metrics to analyse Dishman Carbogen Amc?
What is the 52 Week High and Low of Dishman Carbogen Amc?
What is the trend of Dishman Carbogen Amc share price?